1. Introduction
brachial plexus block, nausea and vomiting, postoperative pain
ADVERSE EFFECTS, MINOR, POSTOPERATIVE COMPLICATIONS
To explore the early clinical value of enhanced recovery after surgery (ERAS) with interscalene brachial plexus block (ISB) for arthroscopic rotator cuff repair (ARCR). We enrolled 240 patients who underwent arthroscopic rotator cuff repair, randomly divided into 3 groups (n = 80 each). Groups A, B, and C underwent only surgery, surgery + ERAS, and ISB + surgery + ERAS, respectively. We analyzed the clinical data and postoperative indicators for the 3 patient groups. Group comparisons of clinical data and postoperative indicators revealed no significant differences in clinical characteristics (The rotator cuff is composed of the supraspinatus, infraspinatus, subscapularis, and teres minor muscles, and is primarily responsible for rotational movements of the shoulder joint and maintaining shoulder stability. The prevalence of rotator cuff injuries can reach 30% to 50% in individuals over age 50.Interscalene brachial plexus block (ISB) provides effective analgesia by blocking conduction of painful stimuli, reducing dosage of intraoperative and postoperative analgesics, and consequently reducing the incidence of adverse effects, such as nausea and vomiting.Therefore, the present study was conducted to answer the following questions: How effective are ERAS with ISB and ERAS alone compared to conventional treatment for control of early postoperative pain? Are there differences in the length of hospital stay (LOS) and early functional outcomes? Are there differences in the incidence of postoperative complications? Answers to these questions will provide valuable evidence for future clinical treatments.